RecruitingNCT05339568

Patient's Whole Process Follow-up Management(HOPE-1)

A Multicenter, Randomized, Open, Parallel Grouping, Investigator-initiated Study Evaluating the Long-term Benefit of Patients With Locally Advanced/Metastatic Non-small Cell Lung Cancer Followed up Using a Patient-wide Management Platform


Sponsor

Qianfoshan Hospital

Enrollment

1,268 participants

Start Date

May 22, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Our project is going to explore whether management and follow-up of locally advanced/metastatic patients using the patient process management platform can prolong patient survival and improve patient quality of life.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is following patients with advanced non-small cell lung cancer (NSCLC) through their entire treatment journey using a smartphone-based follow-up system, to learn more about real-world treatment outcomes and quality of life. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with stage IIB, III, or IV non-small cell lung cancer (confirmed by biopsy or cell testing) - Your cancer is not suitable for curative surgery, or you have declined surgery - Your expected survival is at least 3 months - You own and can use a smartphone **You may NOT be eligible if...** - You have a mental illness that would affect participation - You have another active cancer - You are expected to have curative surgery - You are currently participating in another clinical trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatients' whole process follow-up and management platform

Patients' whole process follow-up and management platform is a software for the patients and investigators. This platform will use to collect patients' information when they are out of patients and will provide the patients' education materials.


Locations(1)

The First Affiliated Hospital of Shandong First Medical University

Jinan, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05339568


Related Trials